| |
|
 |
|
|
|
|
| |
Mon 23 Jun 2008
- Fri 27 Jun 2008
Clontarf Castle Hotel, Dublin, Ireland (Republic of)
|
|
|
|
Over the past seven years Informa Life Sciences has hosted THE European event for the antibodies community. Following on from the incredible success of last year’s event we are proud to announce the return of Recombinant Antibodies with a brand new and updated agenda. Join us this June in Dublin to hear the very latest updates in discovery and development of therapeutic antibodies, from display and selection technologies to clinical feedback on long term antibody therapy.
|
| |
|
An absolute must for anybody wanting to keep up with the field of antibody engineering. (UCL 2007 delegate)
|
|
| |
|
|
Don't Miss
Pre-Conference Symposium: Monday 23 June 2008
LATEST DEVELOPMENTS IN ANTIBODY DISPLAY AND SELECTION TECHNIQUES
Registration: 10:00 Start: 10:30 End: 16:30
Evening Seminar, Discussion Session and Dinner: Tuesday 24 June 2008
BUSINESS OF ANTIBODIES
Registration: 09:30 Start: 10:00 End 16:30
Post-Conference Workshop: Friday 27 June 2008
A-Z OF THERAPEUTIC ANTIBODIES
Registration: 18:00 Start: 18:30 End: 21:30
|
|
Key Presentations
• Dr Mike Clark, Department of Pathology, University of Cambridge, UK
• Professor Patrick Baeuerle, Chief Scientific Officer, Micromet AG, Germany
• Professor Inger Sandlie, Department of Molecular Biosciences, University of Oslo, Norway
• Dr Andreas Hohlbaum, Director of Science and Preclinical Development, Pieris AG, Germany
• Dr Richard Begent, Head of Oncology, Royal Free and University College London, UK
• Dr Greg Lazar, Group Leader, Department of Protein Engineering, Xencor, Inc., USA
• Dr Kerry Chester, Oncology Department, University College London, UK
• Professor Agamemnon Epenetos, Chairman, Trojantec, UK
• Dr Lucien Aarden, Head Research Autoimmune Diseases, University of Amsterdam, The Netherlands
• Dr Horst Lindhofer, CEO, TRION Pharma GmbH, Germany
For further speaker details please download the brouchure
Who Will You Meet
Some photos and feedback from the exhibition at Recombinant Antibodies 2007 in June...
 
"This conference gave us superb face-to-face exposure to high-calibre key contacts from the industry we're actively selling into. The lead generation and branding opportunities offered to us were exceptional" Attana
£300 to upgrade your pass to attend all 3 Co-located conferences. Please contact eleanor.head@informa.com
 
Scientific Advisory Board 2008
Informa would like to thank the scientific advisory board for their continuing help in putting the Recombinant Antibodies agenda together.
• Professor Dario Neri, Department of Chemistry and Applied
Bioscience, Swiss Federal Institute of Technology,
Switzerland
· Dr Kerry Chester, Department of Oncology, University
College London, UK
· Dr Hennie Hoogenboom, Chief Scientific Officer, Ablynx NV,
Belgium
· Dr Nils Lonberg, Senior Vice President, Scientific Director,
Medarex, USA
· Professor Roy Jefferis, Division of Immunity and Infection,
University of Birmingham, UK
· Dr Patrick Baeuerle, Chief Scientific Officer, Micromet,
Germany
· Dr Surinder Sharma, Group Head, ADEPT Biology &
Translational Therapeutics, University College London, UK
· Dr Alain Beck, Head of Physico-Chemistry Department, Centre
of Immunology, Pierre Fabre, France
|